Watch Ticker

Edgewise Therapeutics, Inc. Common Stock

Go to Edgewise Therapeutics, Inc. Common Stock Website

$12.95

-0.57 (-4.18%)

Live

Previous Close

$13.515

Day Range

$12.535 - $13.91

Previous Day Range

$12.94 - $13.59

Market Cap

$1.4 billion USD

Day Vol.

796116

Previous Day Vol.

524616

Currency

USD

Primary Exchange

Nasdaq

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapie...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Marketbeat, Benzinga Contributor - Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge

Edgewise Therapeutics' (EWTX) share price surged 50% in a single session due to positive results from early trials of its novel treatment for obstructive hypertrophic cardiomyopathy, a leading cause of sudden cardiac-related death in young people. The company's pipeline and strong financial position also contribute to the positive sentiment.

Related tickers: EWTX.

Read Full Article

Lekha Gupta - Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

Bausch & Lomb and Edgewise Therapeutics were among the top 7 mid-cap stock gainers last week, with Edgewise Therapeutics shares rocketing 50.19% after announcing positive topline data from a clinical trial, and Bausch & Lomb's parent company Bausch Health considering a sale.

Related tickers: EWTX, BLCO, ASND, BHC.

Read Full Article

Trending Tickers

Please sign in to view